Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
deals
life sciences
national blog main
national top stories
new york blog main
3
×
san francisco blog main
boston blog main
cancer
fda
ipo
new york top stories
san diego blog main
san diego top stories
san francisco top stories
startups
venture capital
abbvie
akouos
alex gorsky
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
armo biosciences
ashley mcevoy
astrazeneca
auris health
autoimmune
avalon ventures
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cerovene
clinical trials
coi pharmaceuticals
correlation ventures
What
plans
3
×
deal
ipo
acquiring
acquisitions
advance
announced
auris
billion
bio
biology
builds
buy
cash
ceo
collabs
company
company’s
covid
cytokine
daniel
developer
drugs
enhanced
files
gilead
gilead’s
health
help
initial
introduce
johnson
laying
medical
medicines
money
month
offering
o’day
public
Language
unset
Current search:
biotech
×
plans
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs